
Gem Aromatics Limited IPO
Gem Aromatics Limited IPO is a Mainboard book building IPO. Price band is ₹309 to ₹325 per share. Minimum investment is ₹14,950. Lot size is 46 shares. Open from 19 Aug 2025 to 21 Aug 2025. Allotment on 22 Aug 2025. Listing on 26 Aug 2025 at BSE, NSE. Managed by Motilal Oswal Investment Advisors Ltd. Registrar: Kfin Technologies Limited. Key details for GMP, subscription, price, allotment, and listing in one place.
Gem Aromatics Limited IPO overview
Gem Aromatics Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Gem Aromatics Limited IPO important dates
Gem Aromatics Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 46 | ₹14,950 |
| Retail (Max) | 13 | 598 | ₹1,94,350 |
| S-HNI (Min) | 14 | 644 | ₹2,09,300 |
| S-HNI (UPI) | 33 | 1,518 | ₹4,93,350 |
| S-HNI (Max) | 66 | 3,036 | ₹9,86,700 |
| B-HNI (Min) | 67 | 3,082 | ₹10,01,650 |
About Gem Aromatics Limited IPO
From the company / RHP narrative.
The company's products are used in oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness, pain management, and personal care.
The company provides a total of seventy products, categorized into four distinct groups, which include:
Mint and its derivatives;;
Clove and its derivatives;
Phenol; and
Other synthetic and natural ingredients.
In Fiscal 2025, the company serves 225 customers and 44 international customers across 18 countries, including the Americas, Asia, Africa, and Australia.
The company sells products directly to customers on a business-to-business basis, with export sales through methods including (i) direct sales, (ii) sales via its subsidiary, Gem Aromatics LLC, in the USA, and (iii) sales through third-party agencies.
As of Mar 31, 2025, the company had an in-house R&D team of 13 scientists who pivotally implemented state-of-the-art technology that advanced our formulations in Value-Added Derivatives.
Competitive Strength
A reputable manufacturer of specialty ingredients in India, encompassing essential oils, aroma chemicals, and value-added derivatives.
Wide product range with continuous product development and R&D capabilities.
Long-standing relationship with well-established customers in India and globally
Strategically located Manufacturing Facilities with a focus on sustainability
Experienced Promoters and management team.
Objective of the issue
How the issuer plans to use IPO proceeds.
General Corporate Purposes
Ratings & reviews
Community ratings and reviews — not financial advice.
No ratings yet — be the first to share your experience.
Follow the latest IPO & unlisted research on iOS and Android.
Documents & links
Prospectus, draft filings, and company site open in a new tab.
Registrar
Details about the registrar of the issue.
Issue details
Key details about the issue, including the face value, lot size, and minimum investment.
Related articles
Research posts and updates that reference this company or theme.
Follow the latest IPO & unlisted research on iOS and Android.